vs
Niagen Bioscience, Inc.（NAGE）与REGIS CORP（RGS）财务数据对比。点击上方公司名可切换其他公司
REGIS CORP的季度营收约是Niagen Bioscience, Inc.的1.7倍（$57.1M vs $33.8M），Niagen Bioscience, Inc.净利率更高（12.2% vs 0.8%，领先11.4%），REGIS CORP同比增速更快（22.3% vs 16.2%），过去两年Niagen Bioscience, Inc.的营收复合增速更高（23.6% vs 7.8%）
Niagen Bioscience（原名为ChromaDex）是一家成立于1999年，总部位于加利福尼亚州洛杉矶的生物科技公司。公司业务涵盖标准品、膳食补充剂以及原料技术开发多个领域，目前在纳斯达克挂牌上市。
瑞吉斯公司是一家美国美发沙龙运营商，总部位于明尼苏达州明尼阿波利斯市。截至2021年8月，该集团旗下拥有5563家加盟沙龙以及276家直营门店，是北美地区规模领先的美发沙龙连锁经营企业。
NAGE vs RGS — 直观对比
营收规模更大
RGS
是对方的1.7倍
$33.8M
营收增速更快
RGS
高出6.1%
16.2%
净利率更高
NAGE
高出11.4%
0.8%
两年增速更快
NAGE
近两年复合增速
7.8%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $33.8M | $57.1M |
| 净利润 | $4.1M | $456.0K |
| 毛利率 | 64.1% | — |
| 营业利润率 | 12.1% | 10.8% |
| 净利率 | 12.2% | 0.8% |
| 营收同比 | 16.2% | 22.3% |
| 净利润同比 | -42.4% | -94.0% |
| 每股收益（稀释后） | $0.05 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NAGERGS
| Q4 25 | $33.8M | $57.1M | ||
| Q3 25 | $34.0M | $59.0M | ||
| Q2 25 | $31.1M | $60.4M | ||
| Q1 25 | $30.5M | $57.0M | ||
| Q4 24 | $29.1M | $46.7M | ||
| Q3 24 | $25.6M | $46.1M | ||
| Q2 24 | $22.7M | $49.4M | ||
| Q1 24 | $22.2M | $49.2M |
净利润NAGERGS
| Q4 25 | $4.1M | $456.0K | ||
| Q3 25 | $4.6M | $1.4M | ||
| Q2 25 | $3.6M | $116.5M | ||
| Q1 25 | $5.1M | $250.0K | ||
| Q4 24 | $7.2M | $7.6M | ||
| Q3 24 | $1.9M | $-853.0K | ||
| Q2 24 | $-15.0K | $91.2M | ||
| Q1 24 | $-492.0K | $-2.3M |
毛利率NAGERGS
| Q4 25 | 64.1% | — | ||
| Q3 25 | 64.5% | — | ||
| Q2 25 | 65.0% | — | ||
| Q1 25 | 63.4% | — | ||
| Q4 24 | 62.5% | — | ||
| Q3 24 | 63.5% | — | ||
| Q2 24 | 60.2% | — | ||
| Q1 24 | 60.7% | — |
营业利润率NAGERGS
| Q4 25 | 12.1% | 10.8% | ||
| Q3 25 | 12.5% | 10.0% | ||
| Q2 25 | 10.2% | 12.1% | ||
| Q1 25 | 15.7% | 8.8% | ||
| Q4 24 | 24.4% | 11.8% | ||
| Q3 24 | 6.3% | 4.6% | ||
| Q2 24 | -1.1% | — | ||
| Q1 24 | -3.3% | 8.3% |
净利率NAGERGS
| Q4 25 | 12.2% | 0.8% | ||
| Q3 25 | 13.5% | 2.3% | ||
| Q2 25 | 11.6% | 192.9% | ||
| Q1 25 | 16.6% | 0.4% | ||
| Q4 24 | 24.6% | 16.4% | ||
| Q3 24 | 7.3% | -1.9% | ||
| Q2 24 | -0.1% | 184.7% | ||
| Q1 24 | -2.2% | -4.7% |
每股收益（稀释后）NAGERGS
| Q4 25 | $0.05 | $0.16 | ||
| Q3 25 | $0.05 | $0.49 | ||
| Q2 25 | $0.04 | $43.67 | ||
| Q1 25 | $0.06 | $0.08 | ||
| Q4 24 | $0.10 | $2.71 | ||
| Q3 24 | $0.02 | $-0.36 | ||
| Q2 24 | $0.00 | $38.40 | ||
| Q1 24 | $-0.01 | $-1.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $18.4M |
| 总债务越低越好 | — | $113.3M |
| 股东权益账面价值 | $76.5M | $188.7M |
| 总资产 | $106.4M | $588.3M |
| 负债/权益比越低杠杆越低 | — | 0.60× |
8季度趋势，按日历期对齐
现金及短期投资NAGERGS
| Q4 25 | — | $18.4M | ||
| Q3 25 | $64.1M | $16.6M | ||
| Q2 25 | $60.3M | $17.0M | ||
| Q1 25 | $55.5M | $13.3M | ||
| Q4 24 | $44.5M | $10.2M | ||
| Q3 24 | $32.2M | $6.3M | ||
| Q2 24 | $27.7M | $10.1M | ||
| Q1 24 | $27.4M | $5.9M |
总债务NAGERGS
| Q4 25 | — | $113.3M | ||
| Q3 25 | — | $111.3M | ||
| Q2 25 | — | $110.8M | ||
| Q1 25 | — | $112.0M | ||
| Q4 24 | — | $111.5M | ||
| Q3 24 | — | $95.2M | ||
| Q2 24 | — | $99.5M | ||
| Q1 24 | — | $179.7M |
股东权益NAGERGS
| Q4 25 | $76.5M | $188.7M | ||
| Q3 25 | $70.7M | $187.6M | ||
| Q2 25 | $64.2M | $185.6M | ||
| Q1 25 | $55.3M | $68.6M | ||
| Q4 24 | $46.1M | $66.7M | ||
| Q3 24 | $34.4M | $56.4M | ||
| Q2 24 | $30.7M | $56.8M | ||
| Q1 24 | $29.0M | $-35.8M |
总资产NAGERGS
| Q4 25 | $106.4M | $588.3M | ||
| Q3 25 | $98.1M | $592.1M | ||
| Q2 25 | $91.5M | $599.0M | ||
| Q1 25 | $81.3M | $511.2M | ||
| Q4 24 | $68.3M | $530.1M | ||
| Q3 24 | $56.5M | $508.9M | ||
| Q2 24 | $54.0M | $530.5M | ||
| Q1 24 | $54.1M | $543.7M |
负债/权益比NAGERGS
| Q4 25 | — | 0.60× | ||
| Q3 25 | — | 0.59× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 1.67× | ||
| Q3 24 | — | 1.69× | ||
| Q2 24 | — | 1.75× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $679.0K | $1.7M |
| 自由现金流经营现金流 - 资本支出 | — | $891.0K |
| 自由现金流率自由现金流/营收 | — | 1.6% |
| 资本支出强度资本支出/营收 | — | 1.4% |
| 现金转化率经营现金流/净利润 | 0.16× | 3.65× |
| 过去12个月自由现金流最近4个季度 | — | $14.9M |
8季度趋势，按日历期对齐
经营现金流NAGERGS
| Q4 25 | $679.0K | $1.7M | ||
| Q3 25 | $3.7M | $2.3M | ||
| Q2 25 | $1.3M | $6.8M | ||
| Q1 25 | $7.9M | $6.2M | ||
| Q4 24 | $8.6M | $2.1M | ||
| Q3 24 | $3.5M | $-1.3M | ||
| Q2 24 | $-264.0K | $5.1M | ||
| Q1 24 | $295.0K | $-277.0K |
自由现金流NAGERGS
| Q4 25 | — | $891.0K | ||
| Q3 25 | — | $1.9M | ||
| Q2 25 | — | $6.2M | ||
| Q1 25 | — | $5.9M | ||
| Q4 24 | — | $1.7M | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | — | $5.1M | ||
| Q1 24 | — | $-326.0K |
自由现金流率NAGERGS
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 3.2% | ||
| Q2 25 | — | 10.3% | ||
| Q1 25 | — | 10.3% | ||
| Q4 24 | — | 3.6% | ||
| Q3 24 | — | -3.0% | ||
| Q2 24 | — | 10.3% | ||
| Q1 24 | — | -0.7% |
资本支出强度NAGERGS
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 0.9% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.1% |
现金转化率NAGERGS
| Q4 25 | 0.16× | 3.65× | ||
| Q3 25 | 0.81× | 1.68× | ||
| Q2 25 | 0.35× | 0.06× | ||
| Q1 25 | 1.56× | 24.80× | ||
| Q4 24 | 1.20× | 0.28× | ||
| Q3 24 | 1.86× | — | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NAGE
| TRUNIAGEN Consumer Product | $27.5M | 81% |
| Ingredients Segment | $5.7M | 17% |
| Other | $694.0K | 2% |
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
